Copyright
©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2733-2740
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2733
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2733
Figure 2 Increase of transforming growth factor-β+ regulatory cells in the serum of hepatocellular carcinoma patients.
A: Representative plots for identification of the TGF-β+ Treg cells producing cells in PBMC; B: Analysis of the frequency of TGF-β+ Treg cell from the PBMCs of healthy donors in comparison to HCC patients; C: Analysis of the frequency of TGF-β+ Treg cell from the PBMCs of healthy donors in comparison to HCC patients with tumors at different stages. aP < 0.05, bP < 0.01, cP < 0.001. TGF-β: Transforming growth factor-β; Treg: Regulatory cells; PBMC: Peripheral blood mononuclear cells; HCC: Hepatocellular carcinoma.
- Citation: An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2733-2740
- URL: https://www.wjgnet.com/1007-9327/full/v24/i25/2733.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i25.2733